Houston, TXNCT01913106Now EnrollingIRB Ready

Prostatic Neoplasms Clinical Trial in Houston, TX

Access cutting-edge prostatic neoplasms treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by The Methodist Hospital Research Institute

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access prostatic neoplasms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related prostatic neoplasms treatment provided free

Apply for This Houston Location

Check if you qualify for this prostatic neoplasms clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Prostatic Neoplasms Study in Houston

The purpose of this study is to conduct a Phase I - II clinical trial to extend preclinical studies involving in situ HSV-tk + Valacyclovir gene therapy in combination with brachytherapy for recurrent prostate cancer. This will provide a novel therapeutic approach to prostate cancer and hopefully impact on the development of metastatic disease and the control of preexisting metastasis.

Sponsor: The Methodist Hospital Research Institute

Who Can Participate

Inclusion Criteria

biopsy-proven local recurrence of prostate cancer without metastatic disease after the hormone therapy at least 2 year after the completion of definitive radiation therapy
Zubrod performance status 0-1
WBC ≥ 4,000/μl, platelets ≥ 100,000/μl
hemoglobin ≥ 8.5 mg/dl
normal partial thromboplastin time and prothrombin time
bilirubin \< 1.5 mg/dl, and AST and alanine aminotransferase \< 2.5 times the upper limit of normal
Serum creatinine ≤ 1.6 mg/dl
Must undergo pre-treatment evaluation of tumor extent and tumor measurement
Nutritional and general physical condition must be considered compatible with the proposed radio-therapeutic treatment
Not on any other experimental therapeutic cancer treatment
No active untreated infection
No major medical or psychiatric illness
International Prostate Symptom Score (IPSS) less than 15
Signed study-specific consent form prior to study entry
Prostate volume less than 50 cc
PSA \> 10ng/ml within the past 3 months may enter study

Exclusion Criteria

Symptomatic metastasis disease
Patients with a life expectancy \< 10 years
Patients on corticosteroids or any immunosuppressive drugs.
HIV + patients
Patients with acute infections (viral, bacterial, or fungal infections requiring therapy)
Patients with cirrhosis.
Patients with collagen vascular diseases
International Prostate Symptom Score (IPSS) greater than 15
Prostate volume greater than 50 cc
Second active cancer except cutaneous cancer
Patients with history of allergies to valacyclovir, acyclovier or who cannot take oral pills

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT01913106) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Prostatic Neoplasms Treatment Options in Houston, TX

If you're searching for prostatic neoplasms treatment options in Houston, TX, this clinical trial (NCT01913106) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostatic neoplasms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all prostatic neoplasms clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Houston, TX

See all multiple sclerosis clinical trials recruiting in Houston — not just this study.

Browse Multiple Sclerosis Trials in Houston →

Browse More Trials by Condition

Multiple Sclerosis TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX